Current Infectious Disease Reports

, Volume 2, Issue 4, pp 337–344 | Cite as

Bacterial meningitis: Principles and practical aspects of therapy

  • Steven I. Aronin


Acute bacterial meningitis continues to be associated with significant morbidity and mortality. Recent research efforts to improve outcome for such patients have focused on antibiotic-cerebrospinal fluid interactions, factors influencing antibiotic selection, indications for cranial imaging, the role of anti-inflammatory agents, and the impact of antibiotic timing on outcome. In this article, I use an illustrative case to review timely data on these topics and provide guidelines for the empiric and pathogen-directed treatment of patients with acute bacterial meningitis.


Meningitis Vancomycin Ceftriaxone Cefotaxime Bacterial Meningitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Durand ML, Calderwood SB, Weber DJ, et al.: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993, 328:21–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Aronin SI, Peduzzi P, Quagliarello VJ: Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998, 129:862–869. These authors create and validate a prognostic staging system for adults with community-acquired bacterial meningitis. The article shows that disease severity at the time of antibiotic administration is the most important predictor of outcome; the prognostic staging system is used to evaluate the relationship between antibiotic timing and outcome.PubMedGoogle Scholar
  3. 3.
    Scheld WM, Sande MA: Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. J Clin Invest 1983 71:411–419.PubMedGoogle Scholar
  4. 4.
    Zwahlen A, Nydegger UE, Vaudaux P, et al.: Complementmediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis 1982, 145:635–646.PubMedGoogle Scholar
  5. 5.
    Cherubin CE, Marr JS, Sierra MF, Becker S: Listeria and gram-negative bacillary meningitis in New York City, 1972–1979: frequent causes of meningitis in adults. Am J Med 1981, 71:199–209.PubMedCrossRefGoogle Scholar
  6. 6.
    Lepper M, Dowling H: Treatment of pneumococcal meningitis with penicillin compared with penicillin plus aureomycin. Arch Intern Med 1951, 88:489.Google Scholar
  7. 7.
    Sande MA: Factors influencing the penetration and activity of antibiotics in experimental meningitis. J Infect 1981, 3(suppl):33–38.PubMedCrossRefGoogle Scholar
  8. 8.
    Tauber MG, Doroshow CA, Hackbarth CJ, et al.: Antibacterial activity of b-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. J Infect Dis 1984, 149:568–574.PubMedGoogle Scholar
  9. 9.
    Quagliarello VJ, Long WJ, Scheld WM: Morphological alterations of the blood-brain barrier with experimental meningitis in the rat: temporal sequence and role of encapsulation. J Clin Invest 1986, 77:1084–1095.PubMedCrossRefGoogle Scholar
  10. 10.
    Quagliarello VJ, Ma A, Stukenbrok H, Palade GE: Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat. J Exp Med 1991, 174:657–672.PubMedCrossRefGoogle Scholar
  11. 11.
    Quagliarello VJ, Scheld WM: Drug therapy: treatment of bacterial meningitis. N Engl J Med 1997, 336:708–716. A comprehensive review of the treatment of bacterial meningitis, this article reviews epidemiologic trends of therapeutic importance and principles of antimicrobial therapy for bacterial meningitis. It addresses issues of empirical management of bacterial meningitis, including the timing and selection of antibiotics, and the role of adjunctive corticosteroids.PubMedCrossRefGoogle Scholar
  12. 12.
    Hasbun R, Aronin SI, Quagliarello VJ: Treatment of bacterial meningitis. Compr ther 1999, 25:73–81.PubMedGoogle Scholar
  13. 13.
    Gopal AK, Whitehouse JD, Simel DL, Corey R: Cranial computed tomography before lumbar puncture. Arch Intern Med 1999, 159:2681–2685. This study identifies predictors of new intracranial lesions on CT scan in patients with suspected meningitis. It uses those predictors, in conjunction with the physician’s clinical assessment and the results of a screening questionnaire, to define a subgroup of patients in whom screening CT scanning is likely unnecessary.PubMedCrossRefGoogle Scholar
  14. 14.
    Coant PN, Kornberg AE, Duffy LC, et al.: Blood culture results as determinants in the organism identification of bacterial meningitis. Pediatr Emerg Care 1992, 8:200–205.PubMedCrossRefGoogle Scholar
  15. 15.
    Blazer S, Berant M, Alon U: Bacterial meningitis: effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol 1983, 80:386–387.PubMedGoogle Scholar
  16. 16.
    Davis SD, Hill HR, Feigl P, et al.: Partial antibiotic therapy in Haemophilus influenzae meningitis. Its effect on cerebrospinal fluid abnormalities. Am J Dis Child 1975, 129:802–807.PubMedGoogle Scholar
  17. 17.
    Tunkel AR, Scheld WM: Acute bacterial meningitis. Lancet 1995, 346:1675–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Friedland IR, Klugman KP: Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992, 339:405–408.PubMedCrossRefGoogle Scholar
  19. 19.
    Bradley JS, Connor JD: Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to b-lactam antibiotics. Pediatr Infect Dis J 1991, 10:871–873.PubMedCrossRefGoogle Scholar
  20. 20.
    Viladrich PF, Gudiol F, Linares J, et al.: Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991, 35:2467–2472.PubMedGoogle Scholar
  21. 21.
    Paris MM, Hickey SM, Uscher MI, et al.: Effect of dexamethasone on therapy of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994, 38:1320–4.PubMedGoogle Scholar
  22. 22.
    Aseni F, Otero MC, Perez-Tamarit D: Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. J Chemother 1991, 5:133–134.Google Scholar
  23. 23.
    Lopez E: The Meropenem Study Group: meropenem versus cefotaxime or ceftriaxone for bacterial meningitis. In Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1993. Washington, DC: American Society for Microbiology; 1993:326.Google Scholar
  24. 24.
    Friedland IR, McCracken GH Jr: Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994, 331:377–82.PubMedCrossRefGoogle Scholar
  25. 25.
    Friedland IR, Paris MM, Ehrett S, et al.: Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993, 37:1630–6.PubMedGoogle Scholar
  26. 26.
    Quagliarello VJ, Scheld WM: Bacterial meningitis: pathogenesis, pathophysiology and progress. N Engl J Med 1992, 327:864.PubMedCrossRefGoogle Scholar
  27. 27.
    Tauber MG, Khayam-Bashi H, Sande MA: Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985, 151:528–534.PubMedGoogle Scholar
  28. 28.
    Syrogiannopoulus GA, Olsen KD, Reisch JS, McCracken GH Jr: Dexamethasone in the treatment of Haemophilus influenzae type B meningitis. J Infect Dis 1987, 155:231–239. [Erratum, J Infect Dis 1987, 155:1359].Google Scholar
  29. 29.
    Geiman BJ, Smith AL: Dexamethasone and bacterial meningitis: a meta-analysis of randomized controlled trials. West J Med 1992, 157:27–31.PubMedGoogle Scholar
  30. 30.
    Saez-Llorens X, McCracken GH Jr: Initial management of bacterial meningitis: steroids and antibiotics. Residence Staff Physician 1993, 39:25–29.Google Scholar
  31. 31.
    McIntyre PB, Berkey CS, King SM, et al.: Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997, 278:925–931. This study analyzes 11 randomized, concurrently controlled trials of dexamethasone therapy in childhood bacterial meningitis. It shows dexamethasone to be efficacious in children with Haemophilus influenzae type b meningitis. It also shows the importance of early administration of dexamethasone in relation to antibiotics in children with pneumococcal meningitis.PubMedCrossRefGoogle Scholar
  32. 32.
    Girgis NI, Farid Z, Mikhail IA, et al.: Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989, 8:848–851. While this study is neither placebo-controlled nor double-blinded, it is the only prospective study to date showing dexamethasone’s efficacy for adults with bacterial meningitis. Adults with pneumococcal meningitis treated with antibiotics plus dexamethasone had a significant reduction in both neurological morbidity and mortality, compared with those treated with antibiotics alone.PubMedCrossRefGoogle Scholar
  33. 33.
    Saez-Llorens X, McCracken GH Jr: Antimicrobial and antiinflammatory treatment of bacterial meningitis. Infect Dis Clin North Am 1999, 13:619–636.PubMedCrossRefGoogle Scholar
  34. 34.
    Radetsky M: Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992, 11:694–698.PubMedCrossRefGoogle Scholar
  35. 35.
    Wenger JD, Hightower AW, Facklam RR, et al.: Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990, 162:1316–1323.PubMedGoogle Scholar
  36. 36.
    Van Esso D, Fontanals D, Uriz S, et al.: Neisseria meningitidis strains with decreased susceptibility to penicillin. Pediatr Infect Dis J 1987, 6:438–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Saez-Nieto JA, Lujan R, Berron S, et al.: Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis 1992, 14:394–402.PubMedGoogle Scholar
  38. 38.
    Woods CR, Smith AL, Wasilauskas BL, et al.: Invasive disease caused by Neisseria meningitidis relatively resistant to penicillin in North Carolina. J Infect Dis 1994, 170:453–456.PubMedGoogle Scholar
  39. 39.
    Dillon JR, Pauze M, Yeung K-H: Spread of penicillinase-producing and transfer plasmids from the gonococcus to Neisseria meningitidis. Lancet 1983, 1:779–781.PubMedCrossRefGoogle Scholar
  40. 40.
    Deveikas A, Schauf V, Mizen M, Riff L: Antimicrobial therapy of experimental group B streptococcal infection in mice. Antimicrob Agents Chemother 1977, 11:817–820.Google Scholar
  41. 41.
    Scheld WM, Fletcher DD, Funk FN, Sande MA: Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. J Infect Dis 1979, 140:287–94.PubMedGoogle Scholar
  42. 42.
    Hasbun R, Quagliarello VJ: Use of the quinolones in treatment of bacterial meningitis. In The Quinolones. Edited by Andriole VT. San Diego: Academic Press; 1998:287–301.Google Scholar
  43. 43.
    Kaufman BA, Tunkel AR, Pryor JC, et al.: Meningitis in the neurosurgical patient. Infect Dis Clin North Am 1990, 4:677–701.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Steven I. Aronin
    • 1
  1. 1.Department of Internal Medicine, Section of Infectious DiseasesWaterbury Hospital Health CenterWaterburyUSA

Personalised recommendations